News and Trends 15 May 2017 German Biotech Clears Phase I with New Gene Therapy for Glaucoma …(DME). “We are now moving towards Phase II development in advanced glaucoma but also other TGF-β2 associated diseases such as wet Age-related Macular Degeneration (AMD) and other TGFβ2-associated diseases such… May 15, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2022 Partnership for better understanding of Sjögren’s syndrome announced by Evotec …expand Evotec’s E.MPD database into autoimmune diseases. The conventional symptomatic description of many diseases stands in the way of both diagnosis and effective treatment. “By leveraging PanOmics data, we are… October 26, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018 British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s …blood-brain barrier. Neurodegenerative diseases are a hot topic, with age-related diseases like Alzheimer’s and Parkinson’s rising in prevalence. In the US alone, 5 million people suffer from Alzheimer’s disease, 1… January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2020 Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition …mitochondrial diseases. Through the acquisition, Astellas gains access to Nanna’s drug discovery technology, which focuses on drugs that target the mitochondria, the energy-producing machinery in human cells. In addition to… April 28, 2020 - 3 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2025 Why are there only 20 cell and gene therapies in Europe? …has historically accepted only incremental premiums on incremental innovation, and only if there is robust comparative data. Because of that, insisting on gene therapies for diseases where patients have an… January 24, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2020 Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease …so the medical need is high,” commented Chord Therapeutics’ CEO, Tom Plitz. “Although rare diseases affect only a small proportion of the overall population, these patients affected by rare diseases… October 15, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2022 Providence Therapeutics’ mRNA rabies vaccine hits milestone …Providence’s clinically validated mRNA technology platform. “We are pleased to demonstrate that Providence’s mRNA technology supports development of additional products that fight a number of infectious diseases,” said Brad Sorenson,… December 16, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2023 Five biotech companies making a name for themselves in Vancouver …organ functions to treat diseases; essentially printing materials to be introduced into the human body. The Vancouver-based biotech company has its initial focus on type 1 diabetes and liver diseases…. June 30, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2023 Immune memory research could lead to next generation of epigenetic drugs …memory cells, allowing for a fast activation of these cells. These features are altered in chronic inflammation diseases like asthma and could be important in autoimmune diseases and cancer. The… July 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 17 Apr 2024 Small but mighty: The role of small-molecule drugs in disease treatment …to treat a range of different indications. In this article, we explore the field of small-molecule drugs, including what they are, their advantages and disadvantages, and which diseases they can… April 17, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 22 Jul 2022 The coming of age story of RNAi technology …levels and another for rare hematological diseases like beta-thalassemia and myelodysplastic syndrome. The former silences the LPA gene, lowering lipoprotein(a) levels and reducing the risk of heart diseases and strokes…. July 22, 2022 - 7 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
Podcast 2 Feb 2024 BioSenic showcasing knee osteoarthritis treatment …interesting, powerful drug that could be really revolutionary,” Nicco said. “I think that this compound could be incredibly useful for patients with really difficult diseases, autoimmune diseases, and we should… February 2, 2024 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email